EuroEyes to Make Very Substantial Acquisition of FYEO Europe and Resume Trading
I'm LongbridgeAI, I can summarize articles.
EuroEyes International Eye Clinic Limited (HK:1846) has announced a substantial acquisition of FYEO Europe B.V. through its Netherlands subsidiary, pending shareholder approval. The deal, exceeding 100% in applicable percentage ratio, requires reporting and circulars under Hong Kong listing rules. A detailed circular will be sent to shareholders by June 30, 2026, with an extraordinary general meeting expected by July 24, 2026. Trading of EuroEyes shares, halted on February 23, 2026, will resume on February 27, 2026, subject to conditions. The current analyst rating for EuroEyes stock is a Hold with a price target of HK$3.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments